Cormorant Asset Management, LP - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...6, 7, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-12-08
4:06 pm
Sale
2025-12-0413GEyePoint Pharmaceuticals, Inc.
EYPT
Cormorant Asset Management, LP8,265,000
9.980%
-60,000decrease
(-0.72%)
Filing
History
2025-11-14
1:23 pm
Unchanged
2025-11-0313GCorbus Pharmaceuticals Holdings, Inc.
CRBP
Cormorant Asset Management, LP2,375,000
12.820%
0
(Unchanged)
Filing
History
2025-11-14
1:10 pm
Purchase
2025-09-3013GCabaletta Bio, Inc.
CABA
Cormorant Asset Management, LP9,591,983
9.990%
4,591,983increase
(+91.84%)
Filing
History
2025-11-14
1:10 pm
Sale
2025-09-3013GVYNE Therapeutics Inc.
VYNE
Cormorant Asset Management, LP0
0.000%
-1,370,938decrease
(Position Closed)
Filing
History
2025-11-14
1:09 pm
Purchase
2025-09-3013GRapport Therapeutics, Inc. Common Stock
RAPP
Cormorant Asset Management, LP3,192,521
6.700%
251,600increase
(+8.56%)
Filing
History
2025-11-14
1:08 pm
Sale
2025-09-3013GPraxis Precision Medicines, Inc.
PRAX
Cormorant Asset Management, LP1,000,000
4.000%
-625,000decrease
(-38.46%)
Filing
History
2025-11-14
1:07 pm
Sale
2025-09-3013GKALA BIO, Inc.
KALA
Cormorant Asset Management, LP0
0.000%
-609,027decrease
(Position Closed)
Filing
History
2025-11-14
1:07 pm
Purchase
2025-09-3013GiBio, Inc.
IBIO
Cormorant Asset Management, LP2,248,010
9.990%
2,248,010increase
(New Position)
Filing
History
2025-10-24
4:10 pm
Sale
2025-10-2213DBiomea Fusion, Inc.
BMEA
Cormorant Asset Management, LP1,060,792
1.530%
-2,620,872decrease
(-71.19%)
Filing
History
2025-10-10
4:06 pm
Unchanged
2025-10-0813DBiomea Fusion, Inc.
BMEA
Cormorant Asset Management, LP3,681,664
5.310%
0
(Unchanged)
Filing
History
2025-08-14
3:04 pm
Sale
2025-06-3013GVYNE Therapeutics Inc.
VYNE
Cormorant Asset Management, LP1,370,938
8.230%
-478,652decrease
(-25.88%)
Filing
History
2025-08-14
3:03 pm
Sale
2025-06-3013GPraxis Precision Medicines, Inc.
PRAX
Cormorant Asset Management, LP1,625,000
7.720%
-120,000decrease
(-6.88%)
Filing
History
2025-08-14
3:02 pm
Purchase
2025-06-3013GCabaletta Bio, Inc.
CABA
Cormorant Asset Management, LP5,000,000
5.470%
5,000,000increase
(New Position)
Filing
History
2025-08-14
3:01 pm
Sale
2025-06-3013GBioAge Labs, Inc.
BIOA
Cormorant Asset Management, LP2,140,605
5.970%
-488,924decrease
(-18.59%)
Filing
History
2025-07-22
5:15 pm
Purchase
2025-06-2013DBiomea Fusion, Inc.
BMEA
Cormorant Asset Management, LP3,681,664
6.460%
3,681,664increase
(New Position)
Filing
History
2025-05-19
5:47 pm
Purchase
2025-03-3113GVYNE Therapeutics Inc.
VYNE
Cormorant Asset Management, LP1,849,590
9.990%
1,849,590increase
(New Position)
Filing
History
2025-05-19
3:02 pm
Sale
2025-05-1513GOnKure Therapeutics, Inc.
OKUR
Cormorant Asset Management, LP0
0.000%
-1,837,739decrease
(Position Closed)
Filing
History
2025-05-15
3:03 pm
Unchanged
2025-03-3113GVYNE Therapeutics Inc.
VYNE
Cormorant Asset Management, LP0
0.000%
0
(Unchanged)
Filing
History
2025-05-15
3:01 pm
Purchase
2025-03-3113GPraxis Precision Medicines, Inc.
PRAX
Cormorant Asset Management, LP1,745,000
8.570%
51,781increase
(+3.06%)
Filing
History
2025-05-15
3:00 pm
Purchase
2025-03-3113GCARGO Therapeutics, Inc. Common Stock
CRGX
Cormorant Asset Management, LP3,381,277
7.330%
3,381,277increase
(New Position)
Filing
History
Goto 0, 1, 2, ...6, 7, Next